Cost & Access13 min readUpdated 2026-04-09

    Ozempic Alternative for $99/Month: Same Semaglutide, 90% Less

    Ozempic costs $900+ per month without insurance. Compounded semaglutide contains the identical active ingredient and is available through Trimi for $99/month. Here is everything you need to know.

    Written by Trimi Medical Team. Medically reviewed by Dr. Asad Niazi, MD, MPH. This article explains the difference in cost between Ozempic and compounded semaglutide, how compounding works, and how Trimi delivers the same active ingredient for $99 per month.

    Quick links: Semaglutide treatment, tirzepatide treatment, and why compounded semaglutide is so affordable.

    The Ozempic Price Problem

    Ozempic's list price in the United States sits between $900 and $1,100 per month in 2026. Without insurance that specifically covers the medication — and most commercial plans do not cover Ozempic for weight loss, only for type 2 diabetes — that cost falls entirely on the patient. For the millions of Americans with obesity who could benefit from semaglutide therapy, that price is simply unreachable.

    The math is brutal: at $1,000 per month, a two-year course of treatment costs $24,000 out of pocket. Even patients with insurance face high deductibles, prior authorization requirements, and coverage denials that make access anything but guaranteed. The result is a medication that clinical trials have shown produces 15% average body weight loss — but one that most people who need it cannot afford.

    This is the problem that compounded semaglutide solves. Through providers like Trimi, patients access the same active ingredient — semaglutide — at $99 per month. The savings are not a gimmick or a compromise. They reflect a fundamentally different distribution model that removes the layers of markup built into brand-name pharmaceutical pricing.

    Monthly cost comparison: Ozempic $900–$1,100 without insurance. Compounded semaglutide through Trimi: $99/month, all-inclusive.

    What Is Compounded Semaglutide?

    Compounded semaglutide is a preparation of the semaglutide molecule made by a licensed compounding pharmacy rather than a brand-name manufacturer. Compounding pharmacies have operated legally in the United States for decades, preparing customized medications when commercial alternatives are unavailable, unaffordable, or do not meet a patient's clinical needs.

    The semaglutide molecule itself — the active ingredient responsible for GLP-1 receptor activation, appetite suppression, and weight loss — is identical in both Ozempic and compounded versions. It is a synthetic peptide with a well-characterized chemical structure. There is no "generic" or "inferior" version; the molecule is the molecule.

    What differs is everything around the molecule: the pen injector device, the brand name, the packaging, and the distribution channel. These elements account for the overwhelming majority of Ozempic's retail price. Strip them away, and what remains is a pharmaceutical-grade peptide that compounding pharmacies can prepare at dramatically lower cost.

    Compounded semaglutide is prescribed by a licensed healthcare provider — at Trimi, a board-certified physician — and prepared by an accredited compounding pharmacy. The medication is shipped directly to the patient with syringes for subcutaneous injection. The clinical experience — weekly injections, dose titration, gradual appetite suppression — is the same as with Ozempic.

    Same Active Ingredient: The Science Behind Semaglutide

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It works by mimicking a naturally occurring hormone — GLP-1 — that the gut releases after eating. When semaglutide activates GLP-1 receptors in the brain's hypothalamus, it reduces appetite and food intake. It also slows gastric emptying, which extends the feeling of fullness after meals. In the pancreas, it stimulates insulin secretion in response to elevated blood glucose.

    The landmark STEP 1 clinical trial, published in the New England Journal of Medicine, found that once-weekly semaglutide 2.4mg produced an average 14.9% reduction in body weight over 68 weeks — roughly three times the weight loss achieved with lifestyle intervention alone. Participants lost an average of 33 pounds. These results are consistent across multiple large trials and represent a genuine medical breakthrough.

    This clinical evidence applies to the semaglutide molecule regardless of whether it comes from Novo Nordisk's manufacturing facility or a compounding pharmacy. The molecule that activates GLP-1 receptors in your brain is chemically identical. When you take compounded semaglutide through Trimi, you are getting the same pharmacological agent that produced those clinical trial results.

    Clinical evidence applies to the molecule

    The STEP 1 trial demonstrated 14.9% average weight loss with semaglutide 2.4mg. The molecule in Trimi's compounded semaglutide is chemically identical to the molecule studied in that trial.

    How Trimi's $99/Month Program Works

    Trimi is a telehealth platform that connects patients with board-certified providers for GLP-1 prescriptions. The process is fully online — no in-person visit, no waiting rooms, no referrals. Here is how it works:

    1

    Complete the online health assessment

    A 10 to 15 minute questionnaire covering your medical history, current medications, weight loss goals, and any contraindications to semaglutide. This is the foundation of your clinical consultation.

    2

    Provider review within 24 hours

    A board-certified physician reviews your submission on business days. They evaluate your eligibility based on clinical criteria — typically a BMI of 27 or higher with a weight-related condition, or 30 or higher without.

    3

    Prescription sent to compounding pharmacy

    If approved, your provider writes a prescription for compounded semaglutide at your starting dose. Trimi's partner pharmacies are PCAB-accredited or FDA-registered 503A community sterile-compounding pharmacy.

    4

    Medication shipped to your door

    Your compounded semaglutide, along with syringes, alcohol swabs, and injection instructions, arrives within 5 to 7 business days. Refills are shipped automatically each month.

    5

    Ongoing provider access

    Your $99 monthly fee includes continued access to your provider for dose adjustments, side effect management, and clinical questions. You are never on your own.

    The $99 monthly price is all-inclusive. It covers the medication, the clinical consultation, ongoing provider access, and shipping. There are no hidden fees, no separate consultation charges, and no insurance required. Many patients find the process faster and more convenient than navigating their insurance company to get Ozempic covered — assuming coverage was ever available.

    How to Switch from Ozempic to Compounded Semaglutide

    If you are currently taking Ozempic and want to switch to compounded semaglutide to reduce costs, the process is simpler than most people expect. Since both contain the same active ingredient, there is no washout period and no need to restart dose titration from the beginning.

    The key information your Trimi provider needs is your current Ozempic dose — 0.25mg, 0.5mg, 1mg, or 2mg — and how long you have been at that dose. They will prescribe the equivalent compounded semaglutide dose, and you continue your treatment without interruption. Most patients report no difference in efficacy or side effect profile when switching.

    For a detailed step-by-step guide to the switching process, including what to tell your provider and how to time the transition, see our complete guide to switching from Ozempic to compounded semaglutide.

    Important: Do not discontinue Ozempic before your compounded semaglutide arrives. Time the switch so your first compounded dose aligns with your next scheduled Ozempic injection.

    Who Is a Good Candidate?

    Compounded semaglutide through Trimi is appropriate for adults who meet standard clinical criteria for GLP-1 therapy and who are looking for affordable access. The typical candidate:

    • Has a BMI of 30 or higher (obesity), or BMI 27 or higher with a weight-related condition such as prediabetes, hypertension, or high cholesterol
    • Has struggled with weight loss through diet and exercise alone
    • Cannot afford Ozempic or Wegovy at full retail price
    • Has been denied insurance coverage for brand-name GLP-1 medications
    • Prefers the convenience of telehealth over in-person clinic visits
    • Is not pregnant, breastfeeding, or diagnosed with medullary thyroid carcinoma or MEN2

    The GLP-1 candidate guide provides a more detailed look at eligibility criteria, common contraindications, and how to prepare for your consultation. The BMI requirements article covers how BMI thresholds are applied in clinical practice.

    Quality and Safety: What You Should Know

    The most common concern patients raise about compounded semaglutide is quality. It is a legitimate question. The lower price can feel suspicious — but the economics of compounding, not a reduction in quality, explain the difference.

    Trimi partners with pharmacies that operate under rigorous quality standards. Key markers to look for — and what Trimi's pharmacy partners meet — include:

    • PCAB accreditation or FDA registration as a 503A community sterile-compounding pharmacy
    • Third-party testing for potency, purity, and sterility on every batch
    • Pharmaceutical-grade semaglutide sourced from verified API suppliers
    • Proper cold chain handling during preparation and shipping
    • Compliance with USP 797 sterile compounding standards

    For a comprehensive breakdown of how to evaluate compounding pharmacy quality, see our guide to compounded GLP-1 quality standards. For a deeper explanation of why compounded semaglutide is so much cheaper without being lower quality, read why compounded semaglutide costs $99 instead of $900.

    Realistic Expectations for Weight Loss

    Semaglutide is not a magic solution, but it is among the most effective medical weight loss treatments available. Clinical evidence is consistent: most patients lose between 10% and 17% of their body weight over the course of treatment, with results depending on starting weight, dose achieved, dietary habits, and physical activity.

    The appetite suppression effect — the reduced hunger, the earlier sense of fullness — typically begins within the first week or two. Weight loss results are usually measurable within four to six weeks, become significant by months three to four, and plateau at the maximum therapeutic dose around months six to twelve.

    Semaglutide works best as part of a broader weight management approach that includes dietary changes and regular movement. The medication reduces the biological drive to overeat; the lifestyle work translates that reduced drive into lasting habits. For guidance on supporting your treatment, see our beginner exercise plan for semaglutide.

    Frequently Asked Questions

    Is compounded semaglutide the same as Ozempic?

    Compounded semaglutide contains the identical active molecule — semaglutide — as Ozempic. Both work by activating GLP-1 receptors to reduce appetite, slow gastric emptying, and improve blood sugar regulation. The difference is in manufacturer, packaging, and price. Ozempic is produced by Novo Nordisk and sold through traditional pharmacy channels at $900 to $1,100 per month. Compounded semaglutide is prepared by accredited compounding pharmacies and available through telehealth providers like Trimi starting at $99 per month.

    Why does Ozempic cost so much?

    Ozempic's retail price reflects Novo Nordisk's research and development investment, patent exclusivity, FDA approval costs, branded marketing, and the markups applied across the pharmaceutical supply chain — wholesalers, pharmacy benefit managers, and retail pharmacies each add margin. Without insurance covering weight loss medications, that full list price falls on the patient. Compounded versions bypass every layer of that markup because they are prepared on demand by a compounding pharmacy using bulk pharmaceutical-grade semaglutide.

    Is compounded semaglutide safe at $99 per month?

    Safety does not correlate with price. What matters is the quality standard of the compounding pharmacy. Trimi partners exclusively with PCAB-accredited and FDA-registered 503A compounding facilities that conduct third-party potency, purity, and sterility testing on every batch. The active ingredient is the same pharmaceutical-grade semaglutide used in brand-name products. Patients receive medical supervision throughout treatment — the $99 price reflects streamlined operations and the absence of brand markup, not a compromise in quality.

    Can I use compounded semaglutide for weight loss if I was prescribed Ozempic?

    Yes. If your provider prescribed Ozempic for weight management and you cannot afford it, compounded semaglutide is a viable alternative that delivers the same active ingredient. Trimi's providers can evaluate your medical history and prescribe compounded semaglutide at the dose appropriate for your situation. You do not need to go back to your original prescribing physician — Trimi's telehealth consultation handles everything.

    How fast can I get compounded semaglutide from Trimi?

    Most patients complete the online health assessment in under 15 minutes. A board-certified provider reviews your submission within 24 hours on business days. Once approved, your prescription is sent to the compounding pharmacy, and medication typically arrives within 5 to 7 business days. From start to first dose, most patients are on treatment within one to two weeks.

    Do I need to stop Ozempic before switching to compounded semaglutide?

    No washout period is needed. Since both contain semaglutide, you continue at your current dose with the compounded version. Your Trimi provider will confirm the correct dose based on where you are in the standard titration schedule. Many patients switch mid-prescription cycle — you simply stop filling the Ozempic prescription and begin the compounded version at your next scheduled injection.

    Does Trimi's $99/month include the consultation fee?

    Trimi's $99 per month for compounded semaglutide is all-inclusive — it covers the medication, the clinical consultation, provider access for ongoing questions, and shipping. There are no separate consultation fees, no hidden charges, and no insurance required. The price is transparent and consistent month to month.

    Sources & References

    1. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. NEJM, 2021.
    2. FDA: Compounding and FDA — Questions and Answers.
    3. NABP compounding pharmacy accreditation standards.
    4. Ozempic FDA prescribing information, 2023.
    5. NIDDK: Prescription medications to treat overweight and obesity.
    6. FDA drug shortage database.
    7. Davies M et al. Semaglutide 2.4mg once a week in adults with overweight or obesity: STEP 2 trial. Lancet, 2021.
    8. CMS Medicare Part D formulary coverage guidance.

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. Trimi provides compounded GLP-1 medications through licensed telehealth providers — readers should evaluate all options and consult their own physicians when appropriate.

    What does the published clinical evidence show for compounded semaglutide?

    Peer-reviewed evidence: Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021). Trimi offers compounded semaglutide starting at $99/month on the annual plan, dispensed by 503A community sterile compounding pharmacies (VialsRx — Texas pharmacy license #35264 — and GreenwichRx). Results vary by individual; eligibility is determined by a licensed clinician.

    Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. — STEP 1, NEJM 2021
    Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. — STEP 4, JAMA 2021
    Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. — SELECT, NEJM 2023

    Key Takeaways

    • Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021)
    • Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. (Source: STEP 4, JAMA 2021)
    • Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. (Source: SELECT, NEJM 2023)
    • Semaglutide is the active pharmaceutical ingredient; it is FDA-approved in the corresponding brand finished products (Wegovy and Ozempic). Trimi's compounded preparation of the same active ingredient is prepared per individual prescription by 503A community sterile compounding pharmacies and is not itself FDA-approved as a drug.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Ozempic vs. Trimi Compounded Semaglutide — 2026 Comparison

    Ozempic is Novo Nordisk's FDA-approved brand semaglutide for type 2 diabetes (off-label for weight loss). Trimi dispenses compounded semaglutide at ~90% lower cash-pay cost — same active ingredient.

    Ozempic vs. Trimi Compounded Semaglutide — 2026 Comparison
    Ozempic (Novo Nordisk)Trimi Compounded Semaglutide
    Active ingredientSemaglutideSemaglutide
    FDA indicationType 2 diabetesCompounded per individual clinical need
    Cash-pay price~$968/month$99/month (annual plan)
    Off-label weight-loss useCommon (not FDA-approved for weight loss)Compounded per individual prescription
    PharmacyRetail / specialty pharmacyVialsRx (TX #35264), GreenwichRx (503A)
    Clinician accessPrimary care or endocrinologistBeluga Health 50-state telehealth

    Source: Trimi pricing 2026 + manufacturer list prices

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: April 9, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Really great customer service! Fast shipment.

    Outcome: Fast shipment

    Amy KeithFacebook
    I'm on my 4th week. No side effects. 5 lb loss which seems slow to me. Food noise is much better. We shall see!

    Outcome: 5 lbs lost in 4 weeks; no side effects; food noise reduced

    Lynn SchweitzerFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2032183
    2. Rubino D, Abrahamsson N, Davies M, et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA.Read StudyDOI: 10.1001/jama.2021.3224
    3. Garvey WT, Batterham RL, Bhatta M, et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine.Read StudyDOI: 10.1038/s41591-022-02026-4
    4. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2307563
    5. Marso SP, Bain SC, Consoli A, et al. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa1607141
    6. Perkovic V, Tuttle KR, Rossing P, et al. (2024). Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2403347

    Was this article helpful?

    Keep Reading

    Clinician-reviewed Trimi guide to semaglutide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded semaglutide option compares to brand alternatives.

    Clinician-reviewed Trimi guide to semaglutide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded semaglutide option compares to brand alternatives.

    Clinician-reviewed Trimi guide to semaglutide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded semaglutide option compares to brand alternatives.

    Clinician-reviewed Trimi guide to semaglutide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded semaglutide option compares to brand alternatives.

    Start your GLP-1 journey — from $99/mo

    Get Started